Genome-wide association study of coronary flow reserve assessed by cardiac perfusion PET suggests a role for NF-κB

Rasika Venkatesh1, Tess Cherlin2, Nicole Wayne3

  • 1Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Insights

Coronary microvascular disease (CMVD) impacts ischemic heart disease (IHD). This study used cardiac PET coronary flow reserve (CFR) to identify genetic links to CMVD, revealing a potential role for the NF-κB pathway.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Coronary microvascular disease (CMVD) is a significant contributor to ischemic heart disease (IHD), necessitating deeper mechanistic understanding and novel therapeutic strategies.
  • Quantitative assessment of coronary flow reserve (CFR) using perfusion cardiac positron emission tomography (PET) serves as a key indicator of coronary microvascular function.

Purpose of the Study:

  • To investigate genetic associations with CMVD using CFR as a quantitative measure.
  • To explore novel genetic loci and pathways implicated in CMVD through genome-wide association studies (GWAS).

Main Methods:

  • Gene association study of previously reported IHD loci with cardiac PET-derived CFR.
  • Exploratory genome-wide association study (GWAS) for CFR.
  • Pathway and proteomic analyses to elucidate biological mechanisms.

Main Results:

  • Significant associations were found between known IHD loci and CFR in African (45 loci) and European (18 loci) populations.
  • GWAS identified novel loci associated with CFR.
  • Multi-omic analyses revealed a significant association between CFR-associated loci and the NF-κB pathway, supported by proteomic data.

Conclusions:

  • Genetic factors play a role in coronary microvascular function as measured by CFR.
  • The NF-κB pathway is implicated in the pathophysiology of CMVD.
  • These findings offer potential targets for CMVD therapies.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...